Investing.com - Amgen reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Amgen announced earnings per share of $4.65 on revenue of $6.59B. Analysts polled by Investing.com EPS of $4.39 on revenue of $6.53B.
Amgen 's are up 9% and is trading at $247.90 , still down 4.44% from its 52 week high of $258.45 set on Monday, April 11, 2022.
Amgen shares gained 0.37% to trade at $247.90 in after-hours trade the report.
Amgen follows other major Healthcare sector earnings this month
Amgen's report follows an earnings beat by UnitedHealth on Friday, July 15, 2022, who reported EPS of $5.57 on revenue of $80.33B, EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on Tuesday, July 19, 2022 with second quarter EPS of $2.59 on revenue of $24.02B, for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar